Quest Diagnostics | DGX - Selling And Administration Expenses

Stock Price
185.02
Daily Change
-2.01 -1.07%
Monthly
6.65%
Yearly
13.88%
Q1 Forecast
181.27

Quest Diagnostics reported $501M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Acadia Healthcare USD 2.28B 1.77B Sep/2025
Agilent USD 428M 37M Sep/2025
Baxter International USD 708M 10M Sep/2025
Bruker USD 242.5M 11.1M Sep/2025
Cardinal Health USD 1.46B 23M Sep/2025
Centene USD 3.13B 98M Sep/2025
Charles River Laboratories USD 177.59M 8.23M Sep/2025
Cigna USD 3.19B 242M Sep/2025
Danaher USD 2.03B 35M Dec/2025
DaVita Healthcare Partners USD 414.37M 1.57M Sep/2025
Elevance Health USD 10.91B 309M Dec/2025
Encompass Health USD 56.1M 3.3M Sep/2025
HCA USD 38.4B 978M Sep/2025
Henry Schein USD 760M 17M Sep/2025
Humana USD 3.36B 614M Mar/2025
Illumina USD 256M 59M Sep/2025
IQVIA Holdings USD 514M 5M Sep/2025
Laboratory Of America USD 552.4M 26.9M Sep/2025
McKesson USD 2.07B 122M Sep/2025
Mettler Toledo International USD 248.39M 1.09M Sep/2025
Molina Healthcare USD 1.24B 94M Sep/2025
Owens Minor USD 462.35M 30.72M Mar/2025
Quest Diagnostics USD 501M 15M Sep/2025
Revvity USD 241.91M 9.6M Sep/2025
Tenet Healthcare USD 102M 2.06B Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
UnitedHealth USD 15.22B 1.44B Sep/2025
Universal Health Services USD 414.58M 4.2M Sep/2025
Waters USD 214.23M 12.97M Sep/2025
Zoetis USD 579M 29M Sep/2025